PROSTATE DISEASE

Clinical trials for PROSTATE DISEASE explained in plain language.

Never miss a new study

Get alerted when new PROSTATE DISEASE trials appear

Sign up with your email to follow new studies for PROSTATE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New combo therapy targets tough prostate cancer

Disease control Ongoing

This study tests whether adding the immunotherapy drug nivolumab to standard radiation and hormone therapy is safe and helps delay the progression of a very aggressive type of prostate cancer (Gleason Group 5). About 44 men who have not yet received treatment for their prostate c…

Matched conditions: PROSTATE DISEASE

Phase: PHASE1, PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control

Last updated May 01, 2026 15:58 UTC

PROSTATE DISEASE

Get alerted when new PROSTATE DISEASE trials appear

New combo therapy targets tough prostate cancer